ABOUT US
At Quell we seek to deliver truly innovative, life-changing therapies for our patients. Our vision as a company is to build a major global biopharmaceutical company bringing transformational and valued therapies for a range of autoimmune and inflammatory diseases, as well as preventing rejection in organ transplantation, based on modular engineered Tregs.
OUR COMPANY
Quell Therapeutics Ltd (โQuellโ), the world leader in the development of engineered T-regulatory (Treg) cell therapies for serious medical conditions driven by the immune system, announced it has raised $156 million in an oversubscribed Series B financing. The financing round was co-led by Jeito Capital, Ridgeback Capital Investments, SV Health Investors and Fidelity Management & Research Company LLC with participation from founding investor Syncona. New investors include British Patient Capital through its Future Fund: Breakthrough program, Janus Henderson Investors, Monashee Investment Management, Point72 and funds managed by Tekla Capital Management LLC
Fantastic collaborative environment at Translation & Innovation Hub - White City, London, and Guys and St Thomas Trust, London. Investment including brand new lab equipment, innovative methods, and exposure to cutting edge technology.
THE ROLE
Quell is looking for Research Associate to play a crucial part in the development and implementation of clinical assays within the Translational Immune Monitoring Team. The Immune Monitoring Team work closely other teams across the organisation to support our clinical trials and are responsible for designing and running assays to explore the pharmacodynamics and mechanism of action of our drugs in patients. This position offers an excellent opportunity for a talented and motivated scientist to contribute to our understanding of how CAR-Treg behave in patients and to support a growing pipeline of assets in an exciting and highly dynamic environment focused on developing cutting-edge cellular therapies.
MAIN RESPONSIBITIES
SKILLS & EXPERIENCE
ESENTIAL REQUIREMENTS
BENEFITS